Citigroup’s Alimera Sciences ALIM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,679
| Closed | -$26K | – | 5842 |
|
|
2024
Q2 | $26K | Sell |
4,679
-56,741
| -92% | -$202K | ﹤0.01% | 4920 |
|
|
2024
Q1 | $240K | Buy |
61,420
+30,612
| +99% | +$117K | ﹤0.01% | 3924 |
|
|
2023
Q4 | $133K | Buy |
30,808
+29,208
| +1,826% | +$98.7K | ﹤0.01% | 4090 |
|
|
2023
Q3 | $4.96K | Buy |
+1,600
| New | +$5.29K | ﹤0.01% | 4723 |
|
|
2022
Q3 | – | Sell |
-7
| Closed | – | – | 6447 |
|
|
2022
Q2 | $0 | Sell |
7
-1,952
| -100% | -$10.7K | ﹤0.01% | 6772 |
|
|
2022
Q1 | $11K | Buy |
+1,959
| New | +$9.54K | ﹤0.01% | 5495 |
|
|
2016
Q2 | – | Sell |
-1,814
| Closed | -$48K | – | 7505 |
|
|
2016
Q1 | $48K | Buy |
1,814
+1,063
| +142% | +$33.1K | ﹤0.01% | 6138 |
|
|
2015
Q4 | $27K | Buy |
751
+454
| +153% | +$19.7K | ﹤0.01% | 6336 |
|
|
2015
Q3 | $10K | Sell |
297
-243
| -45% | -$13.7K | ﹤0.01% | 6440 |
|
|
2015
Q2 | $38K | Sell |
540
-82
| -13% | -$5.66K | ﹤0.01% | 5720 |
|
|
2015
Q1 | $46K | Sell |
622
-436
| -41% | -$34.3K | ﹤0.01% | 5582 |
|
|
2014
Q4 | $88K | Buy |
1,058
+857
| +426% | +$69.6K | ﹤0.01% | 5337 |
|
|
2014
Q3 | $16K | Sell |
201
-15
| -7% | -$1.28K | ﹤0.01% | 6031 |
|
|
2014
Q2 | $20K | Sell |
216
-1,617
| -88% | -$144K | ﹤0.01% | 5807 |
|
|
2014
Q1 | $217K | Buy |
1,833
+1,155
| +170% | +$112K | ﹤0.01% | 4254 |
|
|
2013
Q4 | $48K | Buy |
678
+535
| +374% | +$21.8K | ﹤0.01% | 5745 |
|
|
2013
Q3 | $8K | Buy |
143
+2
| +1% | +$126 | ﹤0.01% | 6297 |
|
|
2013
Q2 | $10K | Buy |
+141
| New | +$8.14K | ﹤0.01% | 6118 |
|
Citigroup's ALIM Position: Q3 2024 in Review
Citigroup sold out of Alimera Sciences (ALIM) in Q3 2024, closing a stake of 4,679 shares — an estimated $26K sold.
Citigroup first reported a position in ALIM in Q2 2013 and held it in 18 quarters. The position peaked at $240K in Q1 2024. 0 funds tracked by Wall St. Rank hold ALIM as of Q3 2024.
- Citigroup reported no remaining Alimera Sciences position as of Q3 2024 after selling out during the quarter.
- Citigroup sold 4,679 Alimera Sciences shares in Q3 2024, an estimated $26K.
- Citigroup first reported a position in Alimera Sciences in Q2 2013 and held it in 18 quarters.
- Citigroup's Alimera Sciences position peaked at $240K in Q1 2024.
- 0 funds tracked by Wall St. Rank held Alimera Sciences as of Q3 2024.
Based on Citigroup's 13F filing for Q3 2024, filed 12 Nov 2024.